Press "Enter" to skip to content

New patent expiration for Viiv Hlthcare drug JULUCA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Viiv Hlthcare drug JULUCA

Annual Drug Patent Expirations for JULUCA
Annual Drug Patent Expirations for JULUCA

Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

JULUCA drug price trends.

Drug patent litigation for JULUCA.

This drug has four hundred and fifteen patent family members in fifty-three countries.

The generic ingredient in JULUCA is dolutegravir sodium; rilpivirine hydrochloride. One supplier is listed for this compound. Additional details are available on the dolutegravir sodium; rilpivirine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Viiv Hlthcare drug JULUCA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions